The Valens Company Inc. (VLNS)
The Valens Company Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.76, up 0.00% on the session, giving a market capitalisation of $61.5M. Its beta of 0.00 implies it has historically moved less than the broad market.
The Valens Company Inc. is a Canadian-headquartered enterprise with international reach, focused on the development, manufacturing, and sale of cannabinoid-based products. Its product portfolio encompasses dried cannabis and hemp biomass, alongside a wide array of consumer goods such as tinctures, two-piece caps, soft gels, oral sprays, vape pens, beverages, diverse concentrates, topicals, edibles, and natural health products. Additionally, Valens provides a comprehensive suite of services, including various extraction techniques (CO2, ethanol, hydrocarbon, solvent-less, and terpene), analytical testing, formulation, product development, and custom manufacturing. The company, formerly known as Valens Groworks Corp., officially changed its name to The Valens Company Inc. in June 2020.
The Valens Company Inc. is most often compared with the following Healthcare names: